Stories

OHSU aumenta el salario mínimo para todos los puestos del convenio AFSCME Local 328

By Sara Hottman February 17, 2023

El aumento a $18 la hora está $3.25 por encima del salario mínimo del área metropolitana de Portland; el objetivo es mejorar la contratación y retención de empleados.

OHSU increases minimum wage for all AFSCME Local 328-represented positions

By Sara Hottman February 17, 2023

Increase to $18 per hour is $3.25 more than Portland metro area minimum wage; aimed at improving recruitment, retention.

Session Eight OHSU + ONA Bargaining update

February 16, 2023

Teams reconvened negotiations with a virtual meeting.

OHSU study finds significant gaps in menstrual research and clinical care

By Nicole Rideout February 15, 2023

Physician-scientists with OHSU Center for Women’s Health urge prioritization of sustainable, accessible, inclusive menstrual technology.

Un estudio de OHSU encuentra importantes brechas en la investigación sobre la menstruación y el cuidado clínico

By Nicole Rideout February 15, 2023

El equipo médico científico de OHSU Center for Women’s Health insta a priorizar la tecnología menstrual sostenible, accesible e inclusiva.

OHSU physician-scientist elected to National Academy of Engineering

By Franny White February 13, 2023

David Huang, M.D., Ph.D., recognized for co-creating widely used medical imaging technology.

OHSU confirma el primer modelo de primate no humano para estudiar el síndrome de Usher

By Franny White February 13, 2023

Ahora los investigadores tienen un modelo para probar la terapia genética en el tratamiento de la principal causa de ceguera y sordera.

OHSU confirms first nonhuman primate model of Usher syndrome

By Franny White February 13, 2023

Researchers now have a model for testing gene therapy as a treatment for leading cause of blindness-deafness.

Investigadores de OHSU identifican un promisorio tratamiento de última generación contra el cáncer

By Joe Rojas-Burke February 10, 2023

El descubrimiento de un químico apunta a la creación de inhibidores de PARP-1 de última generación, un objetivo crítico en cánceres de ovario, mama y próstata.

OHSU researchers identify promising next-generation cancer treatment

By Joe Rojas-Burke February 10, 2023

Chemistry discovery points to next generation inhibitors of PARP-1, a critical target in ovarian, breast and prostate cancers.

Stories

OHSU in the News